Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation

Helai P. Mohammad, Yi Cai, Kelly M. McGarvey, Hariharan Easwaran, Leander Van Neste, Joyce E. Ohm, Heather O'Hagan, Stephen B. Baylin

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Epigenetic silencing of genes in association with aberrant promoter DNA hypermethylation has emerged as a significant mechanism in the development of human cancers. Such genes are also often targets of the polycomb group repressive complexes in embryonic cells. The polycomb repressive complex 2 (PRC2) has been best studied in this regard. We now examine a link between PRC1 and cancer-specific gene silencing. Here, we show a novel and direct association between a constituent of the PRC1 complex, CBX7, with gene repression and promoter DNA hypermethylation of genes frequently silenced in cancer. CBX7 is able to complex with DNA methyltransferase (DNMT) enzymes, leading us to explore a role for CBX7 in maintenance and initiation of gene silencing. Knockdown of CBX7 was unable to relieve suppression of deeply silenced genes in cancer cells; however, in embryonal carcinoma (EC) cells, CBX7 can initiate stable repression of genes that are frequently silenced in adult cancers. Furthermore, we are able to observe assembly of DNMTs at CBX7 target gene promoters. Sustained expression of CBX7 in EC cells confers a growth advantage and resistance to retinoic acid-induced differentiation. In this setting, especially, there is increased promoter DNA hypermethylation for many genes by analysis of specific genes, as well as through epigenomic studies. Our results allow us to propose a potential mechanism through assembly of novel repressive complexes, by which the polycomb component of PRC1 can promote the initiation of epigenetic changes involving abnormal DNA hypermethylation of genes frequently silenced in adult cancers.

Original languageEnglish (US)
Pages (from-to)6322-6330
Number of pages9
JournalCancer Research
Volume69
Issue number15
DOIs
StatePublished - Aug 1 2009
Externally publishedYes

Fingerprint

DNA
Genes
Neoplasms
Gene Silencing
Epigenomics
Embryonal Carcinoma Stem Cells
Neoplasm Genes
Polycomb Repressive Complex 2
Methyltransferases
Human Development
Tretinoin
Maintenance
Enzymes
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mohammad, H. P., Cai, Y., McGarvey, K. M., Easwaran, H., Van Neste, L., Ohm, J. E., ... Baylin, S. B. (2009). Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Research, 69(15), 6322-6330. https://doi.org/10.1158/0008-5472.CAN-09-0065

Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. / Mohammad, Helai P.; Cai, Yi; McGarvey, Kelly M.; Easwaran, Hariharan; Van Neste, Leander; Ohm, Joyce E.; O'Hagan, Heather; Baylin, Stephen B.

In: Cancer Research, Vol. 69, No. 15, 01.08.2009, p. 6322-6330.

Research output: Contribution to journalArticle

Mohammad, Helai P. ; Cai, Yi ; McGarvey, Kelly M. ; Easwaran, Hariharan ; Van Neste, Leander ; Ohm, Joyce E. ; O'Hagan, Heather ; Baylin, Stephen B. / Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. In: Cancer Research. 2009 ; Vol. 69, No. 15. pp. 6322-6330.
@article{b333d896f92146c9b6540fb1b021642a,
title = "Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation",
abstract = "Epigenetic silencing of genes in association with aberrant promoter DNA hypermethylation has emerged as a significant mechanism in the development of human cancers. Such genes are also often targets of the polycomb group repressive complexes in embryonic cells. The polycomb repressive complex 2 (PRC2) has been best studied in this regard. We now examine a link between PRC1 and cancer-specific gene silencing. Here, we show a novel and direct association between a constituent of the PRC1 complex, CBX7, with gene repression and promoter DNA hypermethylation of genes frequently silenced in cancer. CBX7 is able to complex with DNA methyltransferase (DNMT) enzymes, leading us to explore a role for CBX7 in maintenance and initiation of gene silencing. Knockdown of CBX7 was unable to relieve suppression of deeply silenced genes in cancer cells; however, in embryonal carcinoma (EC) cells, CBX7 can initiate stable repression of genes that are frequently silenced in adult cancers. Furthermore, we are able to observe assembly of DNMTs at CBX7 target gene promoters. Sustained expression of CBX7 in EC cells confers a growth advantage and resistance to retinoic acid-induced differentiation. In this setting, especially, there is increased promoter DNA hypermethylation for many genes by analysis of specific genes, as well as through epigenomic studies. Our results allow us to propose a potential mechanism through assembly of novel repressive complexes, by which the polycomb component of PRC1 can promote the initiation of epigenetic changes involving abnormal DNA hypermethylation of genes frequently silenced in adult cancers.",
author = "Mohammad, {Helai P.} and Yi Cai and McGarvey, {Kelly M.} and Hariharan Easwaran and {Van Neste}, Leander and Ohm, {Joyce E.} and Heather O'Hagan and Baylin, {Stephen B.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1158/0008-5472.CAN-09-0065",
language = "English (US)",
volume = "69",
pages = "6322--6330",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation

AU - Mohammad, Helai P.

AU - Cai, Yi

AU - McGarvey, Kelly M.

AU - Easwaran, Hariharan

AU - Van Neste, Leander

AU - Ohm, Joyce E.

AU - O'Hagan, Heather

AU - Baylin, Stephen B.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Epigenetic silencing of genes in association with aberrant promoter DNA hypermethylation has emerged as a significant mechanism in the development of human cancers. Such genes are also often targets of the polycomb group repressive complexes in embryonic cells. The polycomb repressive complex 2 (PRC2) has been best studied in this regard. We now examine a link between PRC1 and cancer-specific gene silencing. Here, we show a novel and direct association between a constituent of the PRC1 complex, CBX7, with gene repression and promoter DNA hypermethylation of genes frequently silenced in cancer. CBX7 is able to complex with DNA methyltransferase (DNMT) enzymes, leading us to explore a role for CBX7 in maintenance and initiation of gene silencing. Knockdown of CBX7 was unable to relieve suppression of deeply silenced genes in cancer cells; however, in embryonal carcinoma (EC) cells, CBX7 can initiate stable repression of genes that are frequently silenced in adult cancers. Furthermore, we are able to observe assembly of DNMTs at CBX7 target gene promoters. Sustained expression of CBX7 in EC cells confers a growth advantage and resistance to retinoic acid-induced differentiation. In this setting, especially, there is increased promoter DNA hypermethylation for many genes by analysis of specific genes, as well as through epigenomic studies. Our results allow us to propose a potential mechanism through assembly of novel repressive complexes, by which the polycomb component of PRC1 can promote the initiation of epigenetic changes involving abnormal DNA hypermethylation of genes frequently silenced in adult cancers.

AB - Epigenetic silencing of genes in association with aberrant promoter DNA hypermethylation has emerged as a significant mechanism in the development of human cancers. Such genes are also often targets of the polycomb group repressive complexes in embryonic cells. The polycomb repressive complex 2 (PRC2) has been best studied in this regard. We now examine a link between PRC1 and cancer-specific gene silencing. Here, we show a novel and direct association between a constituent of the PRC1 complex, CBX7, with gene repression and promoter DNA hypermethylation of genes frequently silenced in cancer. CBX7 is able to complex with DNA methyltransferase (DNMT) enzymes, leading us to explore a role for CBX7 in maintenance and initiation of gene silencing. Knockdown of CBX7 was unable to relieve suppression of deeply silenced genes in cancer cells; however, in embryonal carcinoma (EC) cells, CBX7 can initiate stable repression of genes that are frequently silenced in adult cancers. Furthermore, we are able to observe assembly of DNMTs at CBX7 target gene promoters. Sustained expression of CBX7 in EC cells confers a growth advantage and resistance to retinoic acid-induced differentiation. In this setting, especially, there is increased promoter DNA hypermethylation for many genes by analysis of specific genes, as well as through epigenomic studies. Our results allow us to propose a potential mechanism through assembly of novel repressive complexes, by which the polycomb component of PRC1 can promote the initiation of epigenetic changes involving abnormal DNA hypermethylation of genes frequently silenced in adult cancers.

UR - http://www.scopus.com/inward/record.url?scp=68049137611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049137611&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-0065

DO - 10.1158/0008-5472.CAN-09-0065

M3 - Article

C2 - 19602592

AN - SCOPUS:68049137611

VL - 69

SP - 6322

EP - 6330

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -